Jiang, G., Teramoto, Y., Goto, T., Mizushima, T., Inoue, S., Ide, H., . . . Miyamoto, H. (2021). Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer. Cancers (Basel).
Chicago Style CitationJiang, Guiyang, et al. "Identification of BXDC2 As a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer." Cancers (Basel) 2021.
MLA CitationJiang, Guiyang, et al. "Identification of BXDC2 As a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer." Cancers (Basel) 2021.
Warning: These citations may not always be 100% accurate.